Northwest Biotherapeutics, Inc. (BST:NBYB)
0.2400
+0.0400 (20.00%)
At close: Jul 23, 2025
Northwest Biotherapeutics Revenue
Northwest Biotherapeutics had revenue of $375.00K USD in the quarter ending March 31, 2025, with 32.04% growth. This brings the company's revenue in the last twelve months to $1.47M, up 10.25% year-over-year. In the year 2024, Northwest Biotherapeutics had annual revenue of $1.38M, down -28.47%.
Revenue (ttm)
$1.47M
Revenue Growth
+10.25%
P/S Ratio
236.12
Revenue / Employee
$58.92K
Employees
25
Market Cap
321.78M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.38M | -550.00K | -28.47% |
Dec 31, 2023 | 1.93M | 249.00K | 14.80% |
Dec 31, 2022 | 1.68M | 678.00K | 67.46% |
Dec 31, 2021 | 1.01M | -286.00K | -22.15% |
Dec 31, 2020 | 1.29M | -1.12M | -46.43% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 77.82B |
Deutsche Telekom AG | 120.25B |
Allianz SE | 109.03B |
Rheinmetall AG | 10.48B |
Siemens Energy AG | 37.44B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
Bayerische Motoren Werke Aktiengesellschaft | 139.52B |